2007
DOI: 10.1038/sj.onc.1210674
|View full text |Cite
|
Sign up to set email alerts
|

Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERα-negative and ERα-positive mammary preneoplasia and cancer

Abstract: BRCA1 can regulate estrogen receptor-a (ERa) activity. This study tested the hypotheses that Brca1 loss in mammary epithelium alters the estrogenic growth response and that exposure to increased estrogen or ERa collaborates with Brca1 deficiency to accelerate preneoplasia and cancer development. Longer ductal extension was found in mammary glands of Brca1 f/f;MMTV-Cre mice during puberty as compared to wild-type mice. Terminal end bud differentiation was impaired in Brca1 mutant mice with preservation of prola… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
64
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 63 publications
(67 citation statements)
references
References 40 publications
3
64
0
Order By: Relevance
“…Selective disruption of Brca1 in the mammary glands of Brca1 f/f:MMTV-Cre mutant mice leads to impaired TEB differentiation upon an exposure to estradiol and progesterone [37], and abberant ductal development during pregnancy, lactation and involution [38]. Overexpression of this tumor suppressor, in turn, stimulates lobulo-alveolar development [13], indicating increased epithelial differentiation.…”
Section: Discussionmentioning
confidence: 99%
“…Selective disruption of Brca1 in the mammary glands of Brca1 f/f:MMTV-Cre mutant mice leads to impaired TEB differentiation upon an exposure to estradiol and progesterone [37], and abberant ductal development during pregnancy, lactation and involution [38]. Overexpression of this tumor suppressor, in turn, stimulates lobulo-alveolar development [13], indicating increased epithelial differentiation.…”
Section: Discussionmentioning
confidence: 99%
“…The percentage of ER-positive proliferating cells was significantly increased in all of the in situ proliferations examined, such as ductal carcinoma in situ (DCIS), which correlated positively with the risk of developing breast cancer [16]. Increased ERa expression may be the very earliest change occurring in the tumorigenesis process [17,18] as reported at the very earliest stage of ductal hyperplasia and with increasing atypia in atypical ductal hyperplasias and in ductal carcinoma in situ (DCIS) of low and intermediate nuclear grade [19][20][21].…”
Section: Introductionmentioning
confidence: 94%
“…In the representative experiment presented here, a critical question was to determine if changes in expression levels of genes known to impact mammary cancer risk (Brca1, Tp53,and estrogen receptor 1 (Esr1) 1 ) altered the number of hours between cell divisions (cell lifetime) or impacted the patterns of division (symmetric versus asymmetric) in non-cancerous primary mammary epithelial cells. To accomplish this, individual cell fate maps (trees) were generated using TTT.…”
Section: Representative Resultsmentioning
confidence: 99%
“…For example, genetically engineered mice have shown that the combination of three factors: loss of the full-length breast cancer 1, early onset (Brca1) gene in mammary epithelial cells, tumor protein p53 (Tp53) germ-line haploinsufficiency, and mammary epithelial cell targeted up-regulated Estrogen receptor alpha (ERa) expression results in the development of mammary cancer in 100% of Brca1 haploinsufficiency (<5%). 1 1. Generate primary cultures of preneoplastic mammary epithelial cells from mammary glands of genetically engineered and control wild-type mice.…”
Section: Introductionmentioning
confidence: 99%